Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

BACKGROUND: Interferon alpha (IFNα) therapy has been widely used in the treatment of chronic hepatitis B (CHB) for decades. Nucleos(t)ide analogues are also increasingly used to treat CHB recently. More and more studies are being carried out concerning the clearance or seroconversion of HBsAg, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen-cong, Wang, Mao-rong, Kong, Ling-bo, Ren, Wei-guang, Zhang, Yu-guo, Nan, Yue-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128052/
https://www.ncbi.nlm.nih.gov/pubmed/21651820
http://dx.doi.org/10.1186/1471-2334-11-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128052/
https://www.ncbi.nlm.nih.gov/pubmed/21651820
http://dx.doi.org/10.1186/1471-2334-11-165

Ejemplares similares